Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors throughout the body. An extensive body of published literature supports ...

Accuray (ARAY) announced that the company’s Radixact SynC System and CyberKnife S7 System have been approved by the Chinese National Medical Products Administration. “With these approvals ...

Accuray (NASDAQ:ARAY – Get Free Report ... and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment ...

The company has a P/S ratio of 0.5X compared with the industry’s 4.4X. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Image Source: Zacks Investment Research Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...